Kanecia Obie Zimmerman
Clinical trials sponsored by Kanecia Obie Zimmerman, explained in plain language.
-
Could a COVID pill ease the lingering misery of long haulers?
Disease control CompletedThis study tested if the antiviral medication Paxlovid could help people suffering from Long COVID. Nearly 1,000 participants were randomly assigned to receive either Paxlovid or a placebo control for different lengths of time. Researchers measured if the treatment improved speci…
Phase: PHASE2 • Sponsor: Kanecia Obie Zimmerman • Aim: Disease control
Last updated Apr 02, 2026 14:57 UTC
-
Major trial tests multiple drugs to tackle lingering COVID symptoms
Disease control CompletedThis study tested several different treatments to see if they could help people with Long COVID. It involved 963 adults who had persistent symptoms for at least 12 weeks after a COVID-19 infection. The trial was designed to be flexible, testing whether drugs that target leftover …
Phase: PHASE2 • Sponsor: Kanecia Obie Zimmerman • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
New hope for long COVID's invisible symptoms: trial tests multiple therapies
Symptom relief CompletedThis study tested different treatments to help people with Long COVID who experience problems with their automatic body functions, like dizziness and a racing heart when standing up. It involved 381 adults who had these symptoms for at least 12 weeks after a COVID-19 infection. T…
Phase: PHASE2 • Sponsor: Kanecia Obie Zimmerman • Aim: Symptom relief
Last updated Mar 27, 2026 12:41 UTC
-
Heart drug trial offers hope for debilitating long COVID symptoms
Symptom relief CompletedThis study tested whether a drug called ivabradine could help people with Long COVID who experience dizziness, fatigue, and a racing heart when standing up. In this Phase 2 trial, 181 participants were randomly given either the drug or a placebo to see which was better at reducin…
Phase: PHASE2 • Sponsor: Kanecia Obie Zimmerman • Aim: Symptom relief
Last updated Mar 25, 2026 14:08 UTC